Chief Technology Officer · Structure Therapeutics Inc. (GPCR)

Yingli Ma

FY2025 is the first fiscal year CompBrief holds for Yingli Ma as a named executive officer of Structure Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,998,882

5th of 5 named executive officers at Structure Therapeutics by FY2025 total.

5 named officers on file for Structure Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. Structure Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Structure Therapeutics’s whole pay program stands against its peers

  • Structure Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GPCR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2026 (DEF 14A).

Free

Get Yingli Ma’s full pay file as a PDF — free

More than this page: up to 10 years of Yingli’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Yingli Ma and every company like it: Velarion Intel, free for 3 days, no card →

Yingli Ma compensation by year

Structure Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Structure Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$429,768
Bonus$0
Stock awards$447,734
Option awards$908,788
Non-equity incentive$212,592
Pension and deferred compensation$0
All other$0
Total$1,998,882

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Structure Therapeutics Inc. DEF 14A filed April 23, 2026, accession 0001104659-26-047740, and prior-year filings.

How this page was built: the Structure Therapeutics Inc. filed document, accession 0001104659-26-047740. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU63,810$1,479,329—
RSU27,549$638,678—
RSU12,231$283,555—
Option51,468—$11.75
Option400,000—$2.60
Option155,040—$7.02

Per the Outstanding Equity Awards at Fiscal Year-End table in Structure Therapeutics Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Structure Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Raymond StevensChief Executive Officer and Director$8,429,887
Jun YoonChief Financial Officer$4,467,595
Blai CollChief Medical Officer$3,246,947
Xichen LinChief Scientific Officer$2,480,709
Yingli Ma · this pageChief Technology Officer$1,998,882

Yingli Ma's compensation dossier, Structure Therapeutics

You have read Yingli Ma's totals and holdings. The dossier adds each equity grant Structure Therapeutics disclosed for Yingli Ma and Structure Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Structure Therapeutics compensation record

free company brief

This page is one person within Structure Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Structure Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Structure Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Structure Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Yingli Ma's compensation dossier